| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 10 |
| 1 | ASPIRIN | 10 |
| 2 | ASPIRIN 325 MG | 10 |
| 3 | ASPIRIN 81 MG | 10 |
| 4 | ACETAMINOPHEN 500MG | 8 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 8 |
| 6 | LORAZEPAM | 8 |
| 7 | PAIN RELIEVER | 8 |
| 8 | RIVAROXABAN | 8 |
| 9 | CELECOXIB | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FITUSIRAN | 1 | 0.0179 |
| 1 | TAGRAXOFUSP | 1 | 0.0019 |
| 2 | DACTINOMYCIN | 2 | 0.0009 |
| 3 | ARGATROBAN | 1 | 0.0007 |
| 4 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 5 | DIMENHYDRINATE | 5 | 0.0005 |
| 6 | GLYCERIN SUPPOSITORY | 1 | 0.0004 |
| 7 | GLYCERIN SUPPOSITORIES | 1 | 0.0004 |
| 8 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 9 | HEPARIN SODIUM | 5 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 1 | Benzodiazepine [EPC] | 11 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 3 | Corticosteroid [EPC] | 10 |
| 4 | Factor Xa Inhibitor [EPC] | 10 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 7 |
| 6 | Estrogen [EPC] | 5 |
| 7 | Osmotic Laxative [EPC] | 5 |
| 8 | Progestin [EPC] | 5 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0179 |
| 1 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 2 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 3 | Actinomycin [EPC] | 2 | 0.0009 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 9 | Iron Chelator [EPC] | 2 | 0.0001 |